High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Nadia Arang, J. Silvio Gutkind, Michele Ceribelli et al.|Cell Reports Medicine|2023

Cited by 26